miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
about
Autophagy and urothelial carcinoma of the bladder: A reviewRegulation of multidrug resistance by microRNAs in anti-cancer therapyGenome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma.MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1.Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma.miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker.MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1.Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
P2860
Q26744142-32357DB7-BA77-4A35-9BC5-92151C321F67Q37587311-49BF2204-B45A-4497-A3DF-A7927FE1665CQ37631494-B3045FBF-8805-4C67-86F8-804833B69FC1Q37697052-6612E023-E96B-4F42-A1BD-9023F2501C74Q38700210-0C9B41E2-6ABB-4E30-93E5-63E046BCBBADQ38701227-422B0DA7-7909-4C39-A969-4ED3CAB9F56FQ38742581-DFABB6B2-509D-48A4-8594-C3232875BC77Q38797965-FF21AC6B-4735-4C81-BD43-6687A2EC8B6CQ38839893-01E2C50F-4A83-4C69-9AD3-C2C3627376B3Q39432577-77F2965C-EC1C-4868-8F8C-D5A46A6758B9Q47446459-5C2F3E47-018D-43E9-BE5C-E4E7AED3B161Q48225163-50BC5838-206D-4F6F-B5A5-9A23386DC41FQ48505182-3A1DAF4B-C9F4-4F7A-855A-5B95AC6B8A70Q49681001-BC6875F3-AC9D-49FF-8D63-AB57D1378312Q50638062-63B6609C-54D3-4C44-A4B8-21E3A7C7DA86Q54940097-543FAC78-CF42-4818-937E-96385680EB16Q54981235-CB59C391-BAF0-4291-BEC2-89C43AB1349AQ55262997-D27E28F8-942F-4100-BE54-CA7BB328A1DD
P2860
miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-222 attenuates cisplatin-i ...... R Axis in bladder cancer cells
@en
type
label
miR-222 attenuates cisplatin-i ...... R Axis in bladder cancer cells
@en
prefLabel
miR-222 attenuates cisplatin-i ...... R Axis in bladder cancer cells
@en
P2093
P2860
P356
P1476
miR-222 attenuates cisplatin-i ...... R Axis in bladder cancer cells
@en
P2093
P2860
P304
P356
10.1111/JCMM.12760
P577
2016-01-22T00:00:00Z